Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-884-0 | CAS number: 128-39-2
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Assessment of oral toxicokinetics based on the phys-chem of 2,6 DTBPindicates that the substance is lipophilic and can diffuse across the lipid domain of cellular membranes.
The absorption in the GI tract is expected to occur predominantly via simple diffusion. The mean predicted fractional absorption of 2,6 DTBP in the human is 0.89 (Simcyp v.10.0). Significant first pass effects are not expected for 2,6 DTBP. From the results of the 28-day repeat dose toxicity study in rats there is evidence of systemic exposure to 2,6 DTBP following oral gavage dosing: histopathological examination of the tissues at the end of the study identified changes in the liver in animals dosed at 600 mg/kg body weight/day.Additional evidence of systemic exposure was noted in a preliminary reproduction screening toxicity test study in rats exposed to 2,6 DTBP by oral gavage dosing for between 4 and 6 weeks: animals dosed at 750 mg/kg body weight/day showed severe reactions to treatment with sedation, ataxia, recumbancy, tremors and spasms. Following systemic exposure to 2,6 DTBP in the circulation, a rapid metabolism via glucuronisation and sulphatation may be predicted from the chemical structure with excretion mainly via the kidney. The information for a chemically similar compound would imply a short half life for 2,6 DTBP at the very low level of potential human exposure with no likelihood for bioaccumulation.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 89
- Absorption rate - dermal (%):
- 89
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
